A randomized controlled trial of chemotherapy with 5FU and cisplatin before and after surgery for stage II,III squamous cell carcinoma of the thoracic esophagus (JCOG9907)
Phase 3
- Conditions
- esophageal squamous cell carcinoma
- Registration Number
- JPRN-C000000223
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 330
Inclusion Criteria
Not provided
Exclusion Criteria
(1)severe heart diseases (2)uncontrolable hyper tension or diabetes mellitus (3)severe pulmonary dysfunction (4)HBs positive (5)active bacterial infection (6)synchronous or metachronous (within 5 years) malignancy (7)pregnant female (8)psychiatric medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease free survival
- Secondary Outcome Measures
Name Time Method Overall survival, Toxicity of chemotherapy, Operaive morbidity